NCT07469891 2026-03-13
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Prelude Therapeutics
Phase 1 Not yet recruiting
Prelude Therapeutics
Peking Union Medical College Hospital
Brigham and Women's Hospital
Hospices Civils de Lyon
PharmaEssentia
BeBetter Med Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS